TGF-β1 and TNF-α after red blood cell transfusion in colorectal cancer patients

Experimental Oncology

Volumn 29, Issue 1, 2007, Pages 67-70

  Milasiene, K ^a   Stratilatovas, E ^a   Characiejus, D ^a   Kazbariene, B ^a   Norkiene, V ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Colorectal cancer; Red blood cell transfusion; Transforming growth factor TGF ; Tumor necrosis factor

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TGFB1 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER STAGING; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; BLOOD; COLORECTAL TUMOR; MIDDLE AGED;

AGED; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34248206236     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Miki C, Hiro J, Ojima E, Inoue Y, Mohri Y. Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. Clin Oncol (R Coll Radiol) 2006; 18: 60-6.
2. Jensen LS, Puho E, Pedersen L, Mortensen FV, So rensen HT. Long-term survival rate of patients transfused with leukocyte-depleted and buffy-coat-poor blood during colorectal surgery - secondary publication. An eight-year post-trial follow-up study. Ugeskr Laeger 2006; 168: 481-4.
3. Edna TH, Bjerkeset T. Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer. Dis Colon Rectum 1998; 41: 451-9
4. Skanberg J, Frisk B. Blood transfusion does not influence the development of malignant tumours. Eur J Surg 1999; 165: 528-34.
5. Gorog D, Toth A, Weltner J, Darvas K. The effect of blood transfusion on the late results of the surgical treatment of rectal cancer. Orv Hetil 1996; 37: 1693-8.
6. Landers DF, Hill GE, Wong KC, Fox IJ. Blood transfusion-induced immunomodulation. Anesth Analg 1996; 82: 187-204.
7. Dzik WH, Mincheff M, Puppo F. An alternative mechanism for the immunosuppressive effect of transfusion. Vox Sang 2002; 83: 417-9.
8. Muraoka RS, Dumont N, Ritter CA, DuggerTC, Brant ley DM, Chen J, Easterly E, Roebuck LR, Ryan S, Gotwals PJ, Koteliansky V, Arteaga CL. Blockade of TGF-β inhibits mammary tumors cell viability, migration and metastases. J Clin Invest 2002; 109: 1533-6.
9. Bellone G, Carbone A, Tibaudi D, Mauri F, Ferrero I, Smirne C, Suman F, Rivetti C, Migliaretti G, Camandona M, Palestro G, Emanuelli G, Rodeck U. Differential expression of transforming growth factors - β1, -β2 and -β3 in human colon carcinoma. Eur J Cancer 2001; 37: 224-33.
10. Souchelnytskyi S. Transforming growth factor-signaling and its role in cancer. Exp oncol 2002; 24: 3-12
11. Madhusudan S, Muthuramalingam S, Braybrooke J, Wilner S, Kaur K. Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer. J Clin Oncol 2005; 23: 5950-9.
12. Nikiteas NI, Tzanakis N, Gazouli M, Rallis G, Daniilidis K, Theodoropoulos G. Serum IL-6, TNFa and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol 2005; 11: 1639-43.
13. Narai S, Watanabe M, Hasegawa H, Nishibori H, Endo T, Kubota T, Kitajima M. Significance of transforming growth factor beta 1 as a new tumor marker for colorectal cancer. Int J Cancer 2002; 97: 508-11.
14. Johnson CS, Cook CA, Furmanski P. In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-[alpha]) reversal with exogenous erythropoietin (EPO). Exp Hematol 1990; 18: 109-13.
15. Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 2002; 13: 135-41.
16. Hu J-K, Zhou Z-G, Chen Z-X, Wang L-L, Yu Y-Y, Liu J, Zhang B, Li L, Shu Y, Chen J-P. Comparative evaluation of immune response after laparoscopical and open total mesorectal excisions with anal sphincter preservation in patients with rectal cancer. World J Gastroenterol 2003; 9: 2690-4.
17. Fenwick JC, Cameron M, Naiman SC, Haley LP, Ronco JJ, Wiggs BR, Tweeddale MG. Blood transfusion as cause of leukocytosis in critically ill patients. Lancet 1994; 344: 855-6.
18. Izbicki G, Rudensky B, Na'amad M, Hershko C, Huerta M, Hersch M. Transfusion related leukocytosis in critically ill patients. Crit Care Med 2004; 32: 600-2.